Novo Nordisk
NVO
NVO
706 hedge funds and large institutions have $8.87B invested in Novo Nordisk in 2021 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 259 increasing their positions, 210 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.5% less ownership
Funds ownership: 15.06% → 14.56% (-0.5%)
7% less capital invested
Capital invested by funds: $9.54B → $8.87B (-$665M)
21% less call options, than puts
Call options by funds: $21.8M | Put options by funds: $27.5M
Holders
706
Holding in Top 10
7
Calls
$21.8M
Puts
$27.5M
Top Buyers
| 1 | +$132M | |
| 2 | +$40M | |
| 3 | +$30.3M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$25.2M |
| 5 |
Millennium Management
New York
|
+$25M |
Top Sellers
| 1 | -$142M | |
| 2 | -$101M | |
| 3 | -$48M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$46.5M |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$37.6M |